G1 Therapeutics, Inc.
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001560241
0001560241
EIN:
26-3648180
26-3648180
LEI:
(CF Office: 03 Life Sciences)
Business address:
700 PARK OFFICES DRIVE, SUITE 200, RESEARCH TRIANGLE PARK, NC, 27709
Phone: 919-213-9835
700 PARK OFFICES DRIVE, SUITE 200, RESEARCH TRIANGLE PARK, NC, 27709
Phone: 919-213-9835
Mailing address:
700 PARK OFFICES DRIVE, SUITE 200, RESEARCH TRIANGLE PARK, NC, 27709
700 PARK OFFICES DRIVE, SUITE 200, RESEARCH TRIANGLE PARK, NC, 27709
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Former names:
- G-Zero Therapeutics, Inc. - filings through 2013-04-18
Filings:
562 EDGAR filings since October 12, 2012
562 EDGAR filings since October 12, 2012
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- November 13, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- September 30, 2024 - 15-12G: Securities registration termination [Section 12(g)] Open documentClick to Open document FilingOpen filingClick to Open filing
- September 18, 2024 - S-8 POS: Securities to be offered to employees in employee benefit plans, post-effective amendments Open documentClick to Open document FilingOpen filingClick to Open filing
- September 18, 2024 - S-8 POS: Securities to be offered to employees in employee benefit plans, post-effective amendments Open documentClick to Open document FilingOpen filingClick to Open filing
- September 18, 2024 - S-8 POS: Securities to be offered to employees in employee benefit plans, post-effective amendments Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
No 8-K filing data for this company in last 110 days
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- August 8, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 1, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
- September 18, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- September 18, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- September 18, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- November 13, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- August 19, 2024 - SC 13G: Statement of acquisition of beneficial ownership by individuals Open documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 562 entries
Data source:
CIK0001560241.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
